BD FACS
Total Payments
$585,776
Transactions
51
Doctors
6
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $45,474 | 10 | 0 |
| 2020 | $180,305 | 7 | 0 |
| 2019 | $46,391 | 3 | 0 |
| 2018 | $174,045 | 13 | 1 |
| 2017 | $139,561 | 18 | 5 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $482,450 | 18 | 82.4% |
| Gift | $40,739 | 3 | 7.0% |
| Long term medical supply or device loan | $40,422 | 8 | 6.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,000 | 1 | 1.7% |
| Royalty or License | $4,259 | 2 | 0.7% |
| Consulting Fee | $3,700 | 1 | 0.6% |
| Travel and Lodging | $2,110 | 8 | 0.4% |
| Charitable Contribution | $1,639 | 2 | 0.3% |
| Food and Beverage | $455.89 | 8 | 0.1% |
Payments by Type
Research
$482,450
18 transactions
General
$103,326
33 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| DUET | Becton, Dickinson and Company | $143,052 | 0 |
| SCE Method Comp | Becton, Dickinson and Company | $70,593 | 0 |
| Assay portability | Becton, Dickinson and Company | $68,823 | 0 |
| Method Comparison of the BD Multitest and Tritest reagents on the Investigational BD FACSLyric Clinical Flow Cytometer. | Becton, Dickinson and Company | $55,300 | 0 |
| SCE METHOD COMP | BECTON, DICKINSON AND COMPANY | $41,391 | 0 |
| FACSLyric | Becton, Dickinson and Company | $30,330 | 0 |
| BD FACS | Becton, Dickinson and Company | $14,833 | 0 |
| The Prospective Multi-Site, Events Trial of Vascular Health Profile in Vascular Surgery and Cardiovascular Events | Becton, Dickinson and Company | $14,044 | 0 |
| LYRBC | Becton, Dickinson and Company | $10,500 | 0 |
| Reproducibility of the RUO Multi-color B-Cell Assays Using the Automated Universal Assay Setup Features of the BD FACSLyric and Dry-Format Reagent Panels | Becton, Dickinson and Company | $7,585 | 0 |
| Investigational BD FACSVia Flow Cytometer with BD FACSVia Loader and BD FACSVia Clinical Software using BD Tritest and Multitest IMK Assays | Becton, Dickinson and Company | $2,000 | 0 |
Top Doctors Receiving Payments for BD FACS
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Los Angeles, CA | $579,509 | 34 |
| Brent Wood | Clinical Pathology/Laboratory Medicine | Seattle, WA | $3,700 | 1 |
| , M.D | Specialist | Brentwood, TN | $1,420 | 6 |
| , M.D | Molecular Genetic Pathology | New York, NY | $797.22 | 7 |
| , MD, PHD | Anatomic Pathology & Clinical Pathology | Minneapolis, MN | $187.50 | 1 |
| , M.D | Hematology | Bethesda, MD | $80.80 | 1 |
| , M.D., PH.D | Anatomic Pathology | Gaithersburg, MD | $80.80 | 1 |
Ad
Manufacturing Companies
- Becton, Dickinson and Company $539,385
- BECTON, DICKINSON AND COMPANY $46,391
Product Information
- Type Device
- Total Payments $585,776
- Total Doctors 6
- Transactions 51
About BD FACS
BD FACS is a device associated with $585,776 in payments to 6 healthcare providers, recorded across 51 transactions in the CMS Open Payments database. The primary manufacturer is Becton, Dickinson and Company.
Payment data is available from 2017 to 2021. In 2021, $45,474 was paid across 10 transactions to 0 doctors.
The most common payment nature for BD FACS is "Unspecified" ($482,450, 82.4% of total).
BD FACS is associated with 11 research studies, including "DUET" ($143,052).